Medical/Pharmaceuticals
GLOBAL MEDICAL TECHNOLOGY LEADER ZIMMER BIOMET INCREASES PRESENCE IN MALAYSIA WITH A NEW OFFICE AND GBS CENTER
PETALING JAYA, Malaysia, June 22, 2023 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today officially opened an expanded office and APAC Global Business Services Center (GBS) in Kuala Lumpur, Malaysia. The momentous event was officiated by...
2023-06-22 08:00
5919
European Wellness Signs a Multi-Million MOU for MF3 of Switzerland Supplements & Skincare Exclusivity Distribution for China
BEIJING, June 22, 2023 /PRNewswire/ -- A Memorandum of Understanding (MOU) signing ceremony took place inBeijing, China, and signifies an important step for European Wellness Biomedical Group (EW Group) through its Malaysian subsidiary, European Wellness Academy (EWA), to build a digital technolo...
2023-06-22 07:43
4040
Dr. Yinfei Yin Joins Shanghai ChemPartner as Vice President and Head of Biology and Pharmacology
SHANGHAI, June 21, 2023 /PRNewswire/ -- ChemPartner
2023-06-21 23:07
2201
HistoIndex Presents Advancements in AI-powered Stain-free Tissue Imaging for NASH Clinical Trials at EASL Congress 2023
Data from MAESTRO-NASH study revealed that HistoIndex's technology identified larger percentage of patients who showed improvement after Resmetirom treatment, compared to manual semi-quantitative pathologist-reads Company and collaborators will present 14 accepted abstracts at EASL Congress 2023...
2023-06-21 20:00
2551
Cognizant is Partnering with Accuray to Accelerate Corporate Transformation and Drive Operational Efficiency in Their Radiation Therapy Business
Partnership Will Support Accuray with SAP S/4HANA Implementation TEANECK, N.J., June 21, 2023 /PRNewswire/ -- Cognizant (NASDAQ: CTSH) today announced that it is partnering withAccuray Incorporated (NASDAQ: ARAY) to support the company's deployment of SAP S/4HANA to obtain better data and analyt...
2023-06-21 20:00
2733
Teikoku Pharma granted FDA Fast Track Designation for TPU-006, a Novel 4-day Dexmedetomidine Transdermal System for Post Operative Pain Management
SAN JOSE, June 21, 2023 /PRNewswire/ -- Teikoku Pharma USA, a global pharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) granted Fast Track Designation for TPU-006 in managing postoperative pain. TPU-006 is an investigational 4-day dexmedetomidine transdermal...
2023-06-21 19:05
1969
Telix to Expand Late-Stage Urologic Pipeline with Acquisition of Lightpoint Medical
MELBOURNE, Australia, June 21, 2023 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces it has entered into an agreement to acquire Lightpoint Medical and its SENSEI® radio-guided surgery business. Lightpoint Medical is aUnited Kingdom-based medical device...
2023-06-21 17:32
3061
Novo Nordisk Global Business Services earns the Best Place To Work certificate in India for 2023
BENGALURU, India, June 21, 2023 /PRNewswire/ -- Novo Nordisk Global Business Services (GBS) has been recently awarded as a best place to work inIndia by Best Places to Work – an international HR certification program. The program provides employers in different countries the opportunity to learn ...
2023-06-21 17:07
2426
Mediso receives FDA approval for InterView™ nuclear medicine image processing software
BUDAPEST, Hungary, June 21, 2023 /PRNewswire/ -- Mediso
2023-06-21 16:00
2085
A Decade of Reforming the Japanese Health Care System: OmiGroup Unveils New Brand Identity and The Pioneer Mission for Japan Digital Healthcare
TOKYO, June 19, 2023 /PRNewswire/ -- OmiGroup
2023-06-21 16:00
2509
Manulife Hong Kong Expands its Designated China Hospital Network
* Expanded network now covers over 3,000 listed hospitals across Mainland China * First life insurer in Hong Kong to offer network coverage for all of China's Grade III public hospitals HONG KONG, June 21, 2023 /PRNewswire/ -- Manulife Hong Kong announced today the expansion of its Designated...
2023-06-21 10:40
5700
Jadeite Medicines Receives Orphan Drug Designation for Odevixibat in Progressive Familial Intrahepatic Cholestasis (PFIC) from the Ministry of Health, Labour and Welfare of Japan and will also initiate Phase 3 Trial of Odevixibat in PFIC in Japan
TOKYO, June 20, 2023 /PRNewswire/ -- Jadeite Medicines Inc., (Jadeite Medicines) a clinical stage biopharmaceutical company headquartered inTokyo, Japan (President & CEO, Eiichi Takahashi) has received Orphan Drug Designation for odevixibat for the expected indication of PFIC from the Ministry of...
2023-06-21 09:00
2841
Mediso receives FDA approval for InterView™ nuclear medicine image processing software
BUDAPEST, Hungary, June 21, 2023 /PRNewswire/ -- Mediso
2023-06-21 09:00
3106
Everest Medicines' Partner Calliditas Therapeutics Makes Data Presentations on Nefecon at European Renal Association - European Dialysis and Transplant Association Congress (ERA-EDTA )
SHANGHAI, June 21, 2023 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company") announced today that its partner Calliditas Therapeutics AB (Nasdaq: CALT, Nasdaq Stockholm: CALTX) ("Calliditas") made presentations on data from the NeflgArd Phase 3 Study at the European Renal...
2023-06-21 08:15
4567
Telix Urology Innovation Showcase to be held at The Yale Club, New York City
MELBOURNE, Australia and INDIANAPOLIS, June 21, 2023 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today provides an outline agenda for the Company's briefing session for shareholders to be held on Wednesday, June 21, 2023, at The Yale Club in New York City, from 8.3...
2023-06-21 06:31
2760
IBC Launches Full Range of Best-in-Class Molecular Recognition Technology™ (MRT™) Flowsheets for Highly Selective Separations of Key Radionuclides and Preparation of Novel Chelating Agents for Radionuclide Incorporation into Radiopharmaceuticals
* Development of multiple anticancer drugs with radioisotopes is in progress * Lu-177, Y-90, Cu-67, Ra-223, Ac-225, Pb-212 and At-211 have licensed products or are in clinical trials * IBC's state-of-the-art MRT™ separation and chelation technologies facilitate production of radiopharmaceuti...
2023-06-20 22:21
3048
Growing Awareness of Brain Health for Senior Dogs as Cascade Animal Sciences Launches "Neuro-Pro"
ATLANTA, June 20, 2023 /PRNewswire/ -- Cascade Animal Sciences, an animal health start-up based inthe United States and Australia, is proud to announce the launch of its first dietary supplement product "Neuro-Pro". Neuro-Pro is designed for middle-to-senior-aged dogs and dogs that require neuro...
2023-06-20 22:17
2255
Clarity commences COMBAT theranostic prostate cancer trial in the US
SYDNEY, June 20, 2023 /PRNewswire/ -- Clarity Pharmaceuticals (ASX: CU6) ("Clarity"), a clinical stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for children and adults with cancer, is pleased to announce it has commenced its64C...
2023-06-20 21:03
2030
Longbio Pharma Presented Positive Topline Phase 1 Results for LP-003 at ERS2023
SOFIA, Bulgaria, June 20, 2023 /PRNewswire/ -- Longbio Pharma (Suzhou) Co., Ltd. (abbreviated as "Longbio Pharma"), a pharmaceutical company that develops medicines for the treatment of allergy, asthma, ophthalmology and other autoimmune diseases, announced the preliminary phase I data of LP-003 ...
2023-06-20 21:00
1907
Minghui Pharmaceutical Inc. Announces First Patient Dosing in Phase 1 Clinical Studies of Both the Antibody-Drug Conjugate Programs Targeting TROP-2 or B7-H3 Respectively, for Treatment of Advanced or Metastatic Solid Tumors
SHANGHAI and HANGZHOU, China and WILMINGTON, Del., June 20, 2023 /PRNewswire/ -- Minghui Pharmaceutical, Inc., a leading clinical-stage biopharmaceutical company, announced today that the first dosing has been completed in two phase 1 clinical studies evaluating MHB036C and MHB088C. The studies a...
2023-06-20 18:30
5009
Week's Top Stories
Most Reposted
Agoda releases generative AI film to capture the joy of travel
[Picked up by 349 media titles]
2024-12-10 10:00
Mastercard Economics Institute: APAC growth expected to hold steady in 2025; global policy resets may see shift in gears
[Picked up by 313 media titles]
2024-12-10 09:00Building Asia's Future: Omni HR Secures $7.4mn for HR Tech Expansion
[Picked up by 306 media titles]
2024-12-09 10:00
CCTV+: Yuhang Journey ǀ Follow Olivier to Explore Ancient Liangzhu and Savor Jingshan Tea
[Picked up by 283 media titles]
2024-12-08 20:076th HIIFF Closes with Golden Coconut Award Ceremony
[Picked up by 282 media titles]
2024-12-11 22:19
Most Read
Agoda releases generative AI film to capture the joy of travel
2024-12-10 10:00
3679
Blokees' Figures from Multiple IPs Amaze Fans at 2024 Singapore Comic Con
2024-12-08 00:23
3545
Building Asia's Future: Omni HR Secures $7.4mn for HR Tech Expansion
2024-12-09 10:00
3469